ACST Acasti Pharma Inc.

Acasti Pharma Inc is a biopharmaceutical company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CV:ACST.

As of 09/16/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  
IPO date:  02/11/2013
Outstanding shares:  26,046,944
Average volume:  1,412,355
Market cap:   $57,563,746
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00430K402
Valuation   (See tab for details)
PE ratio:   -4.72
PB ratio:   -7.14
PS ratio:   185.09
Return on equity:   -33.92%
Net income %:   -5,829.58%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy